Gordon MS, Kluger HM, Shapiro G, Kurzrock R, Edelman G, Samuel TA, Moussa AH, Ramies DA, Laird AD, Schimmoller F, et al
First to market Saxenda Although it is not the best known of the four, Saxenda was the first drug of its kind to reach the market in Spain, about four years ago
It combines two well-studied appetite and metabolism targets: amylin signaling (cagrilintide, a longacting amylin analogue) and GLP1 signaling (semaglutide, a GLP1 receptor agonist)
Improving Overall Comfort : If you experience discomfort while injecting, you might hesitate to continue treatment as prescribed
When to choose something simpler If the serum has a very long ingredient list, makes dramatic growth-factor claims, is intended for use after a procedure or repeatedly irritates your skin, a plain peptide moisturiser may be the more comfortable option